Agents targeting the RAAS pathway, such as angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and renin inhibitors, are effective in slowing the progression of diabetic nephropathy [145]. The gene discussed is REN; the disease is diabetic kidney disease.